CLIA-Validated PBMC Spectral Flow Immune Profiling Assay
Clinical trials-grade immunophenotyping with 25 markers for peripheral blood immune detection
Identify immune biomarkers for dose selection, mechanism of action, and pharmacodynamic studies in your clinical trials.
Analyze up to 298 immune cell subsets and states with our 25-marker mass cytometry panel. Accurate subset measurements with <5% coefficient of variation for all major immune cell types.
Total Average Coefficient of Variations:
- Intra-Run Precision: 3.66%
- Inter-Run Precision: 3.45%
Validated with cryopreserved human PBMC.
25-Marker Human PBMC Pan-Immune Profiling Panel
Teiko Bio’s 25-Marker Spectral Flow Pan-Immune Profiling Test includes:
- Markers to identify every major immune cell population and subsets
- 6 functional state markers of maturation, activation, and exhaustion
- Gating performed by our team of expert immunologists
-
T cells
- CD3
- Total T cells
- CD4
- CD4+ T cells
- CD8
- CD8+ T cells
- CD25
- Treg, activation
- CD127
- T cell subsets
- CCR7
- Naive/Memory
- CD45RA
- Naive/Memory
- CD27
- Maturation
- CD28
- Maturation
- TCRgd
- gdT cells
- CD56
- NKT cells
- CD38
- Activation
- HLA-DR
- Activation
- PD-1
- Exhaustion
-
B cells
- CD19
- Total B cells
- CD20
- B cell subsets
- CD27
- Naive/Memory
- IgD
- B cell subsets
- IgM
- B cell subsets
- CD25
- Activation
- HLA-DR
- Antigen presentation
-
NK cells
- CD56
- NK cell subsets
- CD16
- NK cell subsets
- CD38
- Activation
-
Myeloid cells
- CD14
- Monocyte subsets
- CD16
- Monocyte subsets
- CD11c
- Monocytes, macrophages, DCs
- CD123
- pDC
- CD141
- cDC1
- CD1C
- cDC2
- HLA-DR
- Antigen presentation
-
Granulocytes
- CD123
- Basophil
-
General
- CD45
- Total immune cells
- ViaDye
- Viability
Up to 290+ Immune Subsets and States Analyzed
CLIA Validation Data
25-Marker Spectral Flow Pan-Immune Profiling Test for Human PBMCsFill out the form below to access our CLIA Validation plan, report, and data and SOPs.